yes i take peptides · shopping companion
GHRP-6
Category · For EnergyStatus · RUOCitations · 60Cancer Concern · WADA-banned
The verdict
No — the cleaner alternatives do the same job better, and the FDA-approved options for the actual indication (cachexia) outperform GHRP-6.
By source — cost, legality, risk
- BrandNot availableNone — no FDA approvalNo FDA-approved GHRP-6.
- Compounded 503A pharmacy$100–$220/mo where soldRx · niche channelMid. Few compounders carry GHRP-6; appetite mechanic deters clinic-facing programs.
- RUO research peptide$25–$70/moSold 'for research only'Highest. The dominant supply; older synthesis, well-established.
- Gray-market raw$3–$10/moUnregulated overseas importCrypto/Wise pay; same price tier as GHRP-2. WADA-prohibited regardless of source.
Stop signals · abort if
- persistent severe carpal-tunnel symptoms
- new hyperglycemia
- mood changes
- rising IGF-1
- any new mass or unexplained pain
Sources · top 5 of 60
- 01Pombo M, et al. Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiency. Journal of pediatric endocrinology & metabolism : JPEM. 1996;9 Suppl 3:333-8. PMID: 8887178.
- 02Berlanga-Acosta J, et al. Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms. Frontiers in pharmacology. 2024;15:1402138. PMID: 38873418.
- 03Zhao X, et al. Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation. Journal of nanobiotechnology. 2025;24(1):15. PMID: 41327290.
- 04Yu AP, et al. [D-Lys3]-GHRP-6 exhibits pro-autophagic effects on skeletal muscle. Molecular and cellular endocrinology. 2015;401:155-64. PMID: 25450862.
- 05Tian C, et al. GHRP-6 induces CREB phosphorylation and growth hormone secretion via a protein kinase Csigma-dependent pathway in GH3 cells. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban. 2010;30(2):183-7. PMID: 20407870.